|

December 2017 Vol. 5 No.12
Other viewing option
Abstract
• Full
text
•Reprint
(PDF) (221 KB)
Search Pubmed for articles by:
Alghamdi
AH
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 5(12) pp. 600-603,
December, 2017
Copyright © 2017 Merit Research Journals |
|
Case Report
Conjunctival Melanoma in a Patient of Dark
Race |
|
|
Senior
Consultant Ophthalmologist, ASS. Professor, Head of Surgery
Department, and Dean of Faculty of Medicine, Albaha University,
Saudi Arabia.
E-mail: abohani2020@hotmail.com
Accepted November 29, 2017 |
|
|
Conjunctival
melanoma is a somewhat rare condition, relative to choroidal
melanoma and just about 500 times less often than cutaneous
melanoma. Data obtained from several reports revealed that the
more incidence of conjunctival melanoma is among white
population with rare reports among others. Our case is
65-year-old black race, presented with deep brownish to blackish
separated areas in his left eye of four-year duration that
increased in size during the last two months as the patient
noticed. Hence, our presenting case is of great importance and
its significance comes from both its occurrence in a dark race
patient which is very rare relative to that of white race and
also, its development on top benign looking melanocytic lesion.
Ultrasonographic biomicroscopy (UBM) was performed which
revealed that the thickness of tumor is 1.4 mm, and confirmed
the sclera origin of the tumor and not from an extrascleral
extension of a ciliary body melanoma. Histopathology revealed
malignant conjunctival melanoma associated with primary
melanosis with atypia. No metastatic deposits were present as
revealed from results obtained from multiple investigation tools
as histopathological examination of lymph nodes, bone scan, and
computed tomography of the head, neck, chest, and abdomen.
Surgical removal of the tumor, with applying cryotherapy to the
normal-appearing conjunctiva surrounding the lesion was
performed followed by adjuvant treatment in the form of
chemotherapy and topical mitomycin. After the two-year of
follow-up, the patient has no evidence of recurrence which was
evident from the regular periodic investigations hat reflected
on good general condition of our patient.
Keywords: Conjunctiva, Melanoma, Ocular tumor, Dark race
|
|